title: Risk of acute leukemia and myelodysplastic syndromes in patients with monoclonal gammopathy of undetermined significance (MGUS): a population-based study of 17 315 patients.
abstract: The purpose of this study was to determine if there is an increased risk of acute leukemia and myelodysplastic syndromes (MDS) in persons with monoclonal gammopathy of undetermined significance (MGUS). We used a large population-based cohort of individuals systematically screened for the presence or absence of MGUS. MGUS status was then linked to the diagnosis of acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL) and MDS. A total of 17 315 patients age 50 and older (605 MGUS and 16 710 controls) with a cumulative 435 021 person-years of follow-up were studied. MGUS patients had a significantly higher risk of developing MDS compared with controls, hazard ratio 2.4 (95% CI 1.08, 5.32), P=0.031. There was no statistically significant increase in the risk of AML (RR 1.36 P=0.675), and no increased risk of developing ALL.
authors: Mayo Medical School, Mayo Clinic, Rochester, MN, USA.
authors: L E
authors: LE
authors: Roeker
authors: D R
authors: DR
authors: Larson
authors: R A
authors: RA
authors: Kyle
authors: S
authors: S
authors: Kumar
authors: A
authors: A
authors: Dispenzieri
authors: S V
authors: SV
authors: Rajkumar
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D008998:Monoclonal Gammopathy of Undetermined Significance / Q000276:immunology*; D009190:Myelodysplastic Syndromes / Q000276:immunology*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000276:immunology*; D012307:Risk Factors
references: Blood. 2012 Mar 22;119(12):2731-7
references: 22310913
references: N Engl J Med. 2006 Mar 30;354(13):1362-9
references: 16571879
references: N Engl J Med. 2012 May 10;366(19):1782-91
references: 22571202
references: Blood. 2011 Oct 13;118(15):4086-92
references: 21795746
references: N Engl J Med. 1970 Nov 19;283(21):1121-5
references: 5273282
references: N Engl J Med. 1979 Oct 4;301(14):743-8
references: 481481
references: N Engl J Med. 2002 Feb 21;346(8):564-9
references: 11856795
references: N Engl J Med. 2012 May 10;366(19):1759-69
references: 22571200
references: Am J Med. 1978 May;64(5):814-26
references: 645746
references: Br J Haematol. 1996 Nov;95(2):349-53
references: 8904891
references: Mayo Clin Proc. 2009 Aug;84(8):685-93
references: 19648385
references: Br J Haematol. 2003 Jun;121(5):749-57
references: 12780789
references: J Natl Cancer Inst. 2006 Jan 4;98(1):15-25
references: 16391368
references: N Engl J Med. 2012 May 10;366(19):1770-81
references: 22571201
references: Adv Hematol. 2012;2012:801495
references: 22851973
references: Br J Cancer. 1987 May;55(5):523-9
references: 3300761